Clinical Trial Update: A Pilot Study of HSCT for Patients With High-risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen [NA]

View source ↗

Summary

A pilot hematopoietic stem cell transplant study using a nonmyeloablative preparative regimen in patients with high-risk hemoglobinopathies, with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemoglobinopathy
• Sickle Cell Disease
• Thalassemia

Snippet

Sponsor: University of Pittsburgh | Conditions: Sickle Cell Disease, Thalassemia | NA | Status: COMPLETED | Results posted: 2016-08-18